Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016

28 - 29 Oct 2016

Seoul, Korea, Republic of

ESMO Advanced Course Metastatic NSCLC Square

The ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016 was designed for understanding the biology and role of EGFR and TKI’s (1st, 2nd, 3rd generation) in the management of NSCLC; understanding the development of resistance to TKI’s and the available treatment options; understanding the role of T790M in the development of resistance; understanding the utility of different diagnostic methods in identifying the resistance mechanism and understanding the importance of the multidisciplinary team and particularly the pathologist and radiologists in optimising diagnosis and selection of the most appropriate treatment options

Presentations of the ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016 are available according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful links

Hide

There are 12 resources available

28 Oct 2016

ESMO Guidelines in Advanced NSCLC in 2016

Presenter: R. A. Stahel, CH

Session: Session 2 Molecular diagnostics of EGFR and T790Mm Challenges and solutions

Resources:

28 Oct 2016

Strategy to Improve Outcome in EGFR Mutant NSCLC

Presenter: R. Soo, SG

Session: Session 2 Molecular diagnostics of EGFR and T790Mm Challenges and solutions

Resources:

28 Oct 2016

Progression After Third Generation TKI What Next?

Presenter: Y. Ohe, JP

Session: Session 2 Molecular diagnostics of EGFR and T790Mm Challenges and solutions

Resources:

28 Oct 2016

Associations Between Diagnostics and Clinical Outcomes (Incl. Patient Handling Algorithm)

Presenter: J. Youn-Han, KR

Session: Session 2 Molecular diagnostics of EGFR and T790Mm Challenges and solutions

Resources:

28 Oct 2016

Molecular Diagnostics of EGFR and T790M Mutations - Challenges and Solutions

Presenter: J. C. H. Yang, TW

Session: Session 2 Molecular diagnostics of EGFR and T790Mm Challenges and solutions

Resources:

28 Oct 2016

Diagnostic with Alternative Sample Types (Liquid Biopsy)

Presenter: James Chih-Hsin Yang

Session: Session 2 – Molecular diagnostics of EGFR and T790Mm – Challenges and solutions

Resources:

Webcast

28 Oct 2016

Biopsy - Key to the Diagnostics Initially and at Progression

Presenter: E. Thunnissen, NL

Session: Session 2 Molecular diagnostics of EGFR and T790Mm Challenges and solutions

Resources:

28 Oct 2016

Treatment of EGFR Resistant Patients with T790M as Resistance Mechanisms

Presenter: M. Ahn, KR

Session: Session 1 The already long journey of EGFR TKI

Resources:

28 Oct 2016

Mechanisms of 1st Generation Resistance

Presenter: B. C. Cho, KR

Session: Session 1 The already long journey of EGFR TKI

Resources:

28 Oct 2016

Contribution of 2nd Generation TKI in 1st or 2nd Line

Presenter: S. Popat, UK

Session: Session 1 The already long journey of EGFR TKI

Resources: